ARCH Venture Partners portfolio

ARCH Venture Partners (Venture capital) is known to hold 130 companies, 54 of them startups. 51 of them are hiring now, with 3,374 open roles. In the last 12 months rounds in the press named it 5 times (5 as the lead). Its companies closed 17 venture rounds in 12 months, raising $1.8B. Most of them work in Drug Discovery, Cell & Gene Therapy, Biologics & Biosimilars.

Source: Alion Venture capital Oct 21, 2026
Investments
130
54 of them startups
Hiring now
51
3,374 open roles
Deals in 12 months
5
5 as the lead
Rounds in 12 months
17
$1.8B raised
Exits
37

Companies ARCH Venture Partners has invested in

Oratomic Quantum Science & Computing · United States Venture round $475M · this month lead 17 roles round in the pressJul 10
Homeward Primary Care & Medical Centers Series D $120M · this month 2 roles portfolio pageSep 25
Light Cast Medical AI Venture round · 1 mo ago portfolio pageSep 25
Moonwalk Biosciences, Inc. United States Series B $70M · 1 mo ago portfolio pageSep 25
LifeMine Prescription Drugs · United States Venture round $263M · 2 mo ago 1 role portfolio pageSep 25
Trase Nonprofits & Foundations Seed $107M · 3 mo ago lead round in the pressJun 25
Trase AI Agents · United States Seed $107M · 3 mo ago lead 4 roles round in the pressJun 24
Countable Labs Scientific & Lab Software · United States Venture round $26M · 4 mo ago 5 roles portfolio pageSep 25
CREATE Medicines Vaccines · United States Series B $122M · 5 mo ago lead portfolio page, round in the pressMay 14
Moleculent Sweden Venture round $20M · 5 mo ago 2 roles portfolio pageSep 25
bit.bio Synthetic Biology · United Kingdom Venture round · 6 mo ago portfolio pageSep 25
Vizgen Bioinformatics · United States Series E $47.8M · 9 mo ago portfolio pageSep 25
Paradigm Health Clinical Trial Software · United States Series B $78M · 10 mo ago lead 10 roles portfolio page, round in the pressDec 4, 2025
Pheast Therapeutics United States Venture round $24.6M · 12 mo ago portfolio pageSep 25
Treeline Biosciences Drug Discovery · United States Venture round $200.1M · 13 mo ago 7 roles portfolio pageSep 25
Akamis Bio Series A $60M · 22 mo ago portfolio pageSep 25
Metsera Venture round $215M · 23 mo ago portfolio pageSep 25
Rippl Care Coordination & Population Health · United States Venture round $23M · 2 yr ago portfolio pageSep 25
Denali Therapeutics United States Venture round $499.7M · 2 yr ago portfolio pageSep 25
Mirador Therapeutics Drug Discovery · United States Venture round $333M · 2 yr ago 2 roles portfolio pageSep 25
Quantum Circuits Quantum Science & Computing · United States Venture round $26.6M · 2 yr ago portfolio pageSep 25
Basking Biosciences Prescription Drugs · United States Venture round $55M · 2 yr ago portfolio pageSep 25
Gossamer Bio Drug Discovery · United States Venture round $212.1M · 3 yr ago 1 role portfolio pageSep 25
Aledade Care Coordination & Population Health · United States Venture round $260M · 3 yr ago 33 roles portfolio pageSep 25
SunBird Bio Venture round $23.2M · 3 yr ago portfolio pageSep 25
Boundless Bio United States Series C $100M · 3 yr ago portfolio pageSep 25
Accompany Health Primary Care & Medical Centers · United States Venture round $56.3M · 3 yr ago 1 role portfolio pageSep 25
Chroma Bio, Inc. United States Venture round $135M · 3 yr ago portfolio pageSep 25
Protillion Biosciences Biologics & Biosimilars · United States Series A $18M · 3 yr ago lead 1 role portfolio page, round in the pressDec 18, 2022
Synchron Neurotech & Neuromodulation · United States Series C $75M · 3 yr ago 5 roles portfolio pageSep 25
Recurohealth Venture round $27.3M · 4 yr ago portfolio pageSep 25
Skylark Bio United States Venture round $40.9M · 4 yr ago portfolio pageSep 25
Areteia United States Venture round $360M · 4 yr ago portfolio pageSep 25
Altos Labs Regenerative Medicine Venture round $3B · 4 yr ago 13 roles portfolio pageSep 25
Curie.Bio Venture Capital · United States Venture round $12.1M · 4 yr ago portfolio pageSep 25
hC Bioscience Venture round $20M · 4 yr ago portfolio pageSep 25
Arbor Biotechnologies Synthetic Biology · United States Venture round $215M · 4 yr ago 3 roles portfolio pageSep 25
PerkinElmer Laboratory Equipment · United States Venture round $2.2B · 5 yr ago 171 roles portfolio pageSep 25
Genetixbiotx Cell & Gene Therapy · United States Venture round $75M · 5 yr ago 9 roles portfolio pageSep 25
Jaguar Gene Therapy Cell & Gene Therapy Series B $139M · 5 yr ago portfolio pageSep 25
eGenesis Cell & Gene Therapy · United States Venture round $125M · 5 yr ago 9 roles portfolio pageSep 25
insitro Drug Discovery AI · United States Venture round $143M · 6 yr ago 12 roles portfolio pageSep 25
Transcenta Holding Bioprocessing · China Series B $100M · 6 yr ago portfolio pageSep 25
Omniome (Acquired) Venture round $60M · 6 yr ago portfolio pageSep 25
Quanterix Precision Medicine Venture round $6.2M · 7 yr ago portfolio pageSep 25
908Devices Venture round $17.5M · 7 yr ago portfolio pageSep 25
HiberCell United States Venture round $60M · 7 yr ago portfolio pageSep 25
Twist Bioscience Synthetic Biology · United States Venture round $50M · 8 yr ago 39 roles portfolio pageSep 25
Unity Biotechnology Venture round $55M · 8 yr ago portfolio pageSep 25
Juno Therapeutics (Acquired) Venture round $31.1M · 9 yr ago portfolio pageSep 25
Homologymedicines Venture round $83.5M · 9 yr ago portfolio pageSep 25
eGenesis United States Series A $38M · 9 yr ago lead round in the pressMar 16, 2017
Thermo Fisher Scientific Laboratory Equipment · United States 2387 roles portfolio pageSep 25
Illumina Genomics & Genetic Testing · United States 131 roles portfolio pageSep 25
Alnylam Cell & Gene Therapy · United States 91 roles portfolio pageSep 25
Resilience CRO & CDMO Services · United States 80 roles portfolio pageSep 25
Keenova Prescription Drugs 61 roles portfolio pageSep 25
Evotec Drug Discovery · Germany 58 roles portfolio pageSep 25
Scholar Rock Biologics & Biosimilars · United States 31 roles portfolio pageSep 25
Kardigan Cardiometabolic Therapeutics · United States 26 roles portfolio pageSep 25
Xaira Therapeutics Drug Discovery AI · United States 24 roles portfolio pageSep 25
ONI Laboratory Equipment · United States 18 roles portfolio pageSep 25
Parabilis Medicines Prescription Drugs 18 roles portfolio pageSep 25
Generate:Biomedicines Biologics & Biosimilars · United States 17 roles portfolio pageSep 25
Beam Therapeutics Biologics & Biosimilars · United States 15 roles portfolio pageSep 25
GRAIL Diagnostic Tests & IVD · United States 15 roles portfolio pageSep 25
Vir Biotechnology, Inc. Infectious Disease Therapeutics · United States 15 roles portfolio pageSep 25
Dispatch Bio Prescription Drugs · United States 10 roles portfolio pageSep 25
Maze Therapeutics Drug Discovery · United States 8 roles portfolio pageSep 25
Encoded Therapeutics Cell & Gene Therapy · United States 6 roles portfolio pageSep 25
City Therapeutics Drug Discovery · United States 5 roles portfolio pageSep 25
Vividion Therapeutics (Acquired) Drug Discovery · United States 5 roles portfolio pageSep 25
Erasca Prescription Drugs · United States 4 roles portfolio pageSep 25
Kura Oncology Oncology Therapeutics · United States 4 roles portfolio pageSep 25
Remix Therapeutics Drug Discovery · United States 3 roles portfolio pageSep 25
Singular Genomics Systems Genomics & Genetic Testing · United States 3 roles portfolio pageSep 25
Elephas Biosciences Cell & Gene Therapy · United States 2 roles portfolio pageSep 25
Magnet Biomedicine Drug Discovery · United States 2 roles portfolio pageSep 25
Singleron Biotechnologies Genomics & Genetic Testing · Singapore 1 role portfolio pageSep 25
Vilya Drug Discovery · United States 1 role portfolio pageSep 25
Arsenal Bio Cell & Gene Therapy portfolio pageSep 25
Aspen Neuroscience Cell & Gene Therapy portfolio pageSep 25
Browse Happy Adventure Tourism portfolio pageSep 25
Dewpoint Therapeutics Drug Discovery portfolio pageSep 25
12

Open roles at ARCH Venture Partners portfolio companies

3,374 open roles at 51 of its companies

Focus

Markets
Drug Discovery15%
Cell & Gene Therapy8%
Biologics & Biosimilars7%
Oncology Therapeutics6%
Laboratory Equipment5%
Prescription Drugs5%
Precision Medicine4%
Rare Disease Therapeutics4%
Where its companies are
United States44%
China2%
Iceland1%
United Kingdom1%
Germany1%
Sweden1%
Singapore1%
Stage of its companies
Venture, series not stated73%
Series B10%
Series C and later8%
Series A6%
Pre-seed & seed4%

Questions about ARCH Venture Partners

How many companies has ARCH Venture Partners invested in?

ARCH Venture Partners is known to hold 130 companies: 54 startups, and 37 exits so far, read from its own portfolio page and the funding rounds that name it.

Is ARCH Venture Partners investing now?

Yes: in the last 12 months 5 rounds in the press named ARCH Venture Partners (5 as the lead), and 0 companies joined its portfolio page in 90 days.

What does ARCH Venture Partners invest in?

The markets of the companies ARCH Venture Partners holds: Drug Discovery (15%), Cell & Gene Therapy (8%), Biologics & Biosimilars (7%), Oncology Therapeutics (6%), Laboratory Equipment (5%).

Which ARCH Venture Partners portfolio companies are hiring?

51 companies ARCH Venture Partners holds are hiring now, with 3,374 open roles listed on this page.

Who does ARCH Venture Partners invest alongside?

The investors that hold the most companies together with ARCH Venture Partners: GV, F-Prime Capital, General Catalyst, EcoR1 Capital, Andreessen Horowitz.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 18; 9 rounds in the press that name it

ARCH Venture Partners portfolio: 130 known companies. Alion, Oct 21, 2026. https://alion.io/company/arch-venture-partners/portfolio

Licence: CC BY-SA 4.0JSON